0001493152-24-020828 Sample Contracts

Securities Purchase Agreement

Securities Purchase Agreement • May 21st, 2024 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York

• Contract Type
  Securities Purchase Agreement
• Filed
  May 21st, 2024
• Company
  MyMD Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  New York

This Securities Purchase Agreement (the “Agreement”), dated as of May 20, 2024, is by and among MyMD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).

REGISTRATION RIGHTS AGREEMENT

Registration Rights Agreement • May 21st, 2024 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Registration Rights Agreement
• Filed
  May 21st, 2024
• Company
  MyMD Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May 20, 2024, is by and among MyMD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”).

Omnibus Waiver, Consent, Notice and Amendment

Omnibus Waiver, Consent and Amendment • May 21st, 2024 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Omnibus Waiver, Consent and Amendment
• Filed
  May 21st, 2024
• Company
  MyMD Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This Omnibus Waiver, Consent and Amendment (this “Agreement”), dated as of May 20, 2024, is by and among MyMD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investor listed on the signature page attached hereto (the “Investor”).